Dark Forest Capital Management LP Atea Pharmaceuticals, Inc. Transaction History

Dark Forest Capital Management LP

  • $718 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$5.49 - $8.79 $818 - $1,309
-149 Reduced 82.78%
31 $0
Q2 2022

Aug 15, 2022
SELL
$5.33 - $8.18 $9,236 - $14,175
-1,733 Reduced 90.59%
180 $1,000
Q1 2022

May 13, 2022
SELL
$5.5 - $9.19 $147,724 - $246,834
-26,859 Reduced 93.35%
1,913 $13,000
Q4 2021

Feb 11, 2022
BUY
$7.67 - $44.59 $220,681 - $1.28 Million
28,772 New
28,772 $257,000

Others Institutions Holding AVIR

# of Institutions
112
Shares Held
52.4M
Call Options Held
900
Put Options Held
126K
View Full List

About Atea Pharmaceuticals, Inc.

AVIR Quotes by TradingView
  • Ticker AVIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,258,600
  • Market Cap $275M
  • Description
  • Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...
More about AVIR
Track This Portfolio

Track Dark Forest Capital Management LP Portfolio

Follow Dark Forest Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Dark Forest Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email